154 related articles for article (PubMed ID: 20070888)
21. ADAM10 as a major activator of reactive oxygen species production and klotho shedding in podocytes under diabetic conditions.
Piwkowska A; Rachubik P; Typiak M; Kulesza T; Audzeyenka I; Saleem MA; Gruba N; Wysocka M; Lesner A; Rogacka D
Biochem Pharmacol; 2024 Jul; 225():116328. PubMed ID: 38815628
[TBL] [Abstract][Full Text] [Related]
22. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
23. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma.
Ko SY; Lin SC; Wong YK; Liu CJ; Chang KW; Liu TY
Cancer Lett; 2007 Jan; 245(1-2):33-43. PubMed ID: 16309826
[TBL] [Abstract][Full Text] [Related]
24. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
[TBL] [Abstract][Full Text] [Related]
25. Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.
Schramme A; Abdel-Bakky MS; Gutwein P; Obermüller N; Baer PC; Hauser IA; Ludwig A; Gauer S; Schäfer L; Sobkowiak E; Altevogt P; Koziolek M; Kiss E; Gröne HJ; Tikkanen R; Goren I; Radeke H; Pfeilschifter J
Kidney Int; 2008 Aug; 74(3):328-38. PubMed ID: 18480749
[TBL] [Abstract][Full Text] [Related]
26. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
27. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
28. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
[TBL] [Abstract][Full Text] [Related]
29. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
30. Adam10 mediates the choice between principal cells and intercalated cells in the kidney.
Guo Q; Wang Y; Tripathi P; Manda KR; Mukherjee M; Chaklader M; Austin PF; Surendran K; Chen F
J Am Soc Nephrol; 2015 Jan; 26(1):149-59. PubMed ID: 24904084
[TBL] [Abstract][Full Text] [Related]
31. Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme.
Escrevente C; Morais VA; Keller S; Soares CM; Altevogt P; Costa J
Biochim Biophys Acta; 2008 Jun; 1780(6):905-13. PubMed ID: 18381078
[TBL] [Abstract][Full Text] [Related]
32. TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.
Noy PJ; Yang J; Reyat JS; Matthews AL; Charlton AE; Furmston J; Rogers DA; Rainger GE; Tomlinson MG
J Biol Chem; 2016 Feb; 291(7):3145-57. PubMed ID: 26668317
[TBL] [Abstract][Full Text] [Related]
33. L1 stimulation of human glioma cell motility correlates with FAK activation.
Yang M; Li Y; Chilukuri K; Brady OA; Boulos MI; Kappes JC; Galileo DS
J Neurooncol; 2011 Oct; 105(1):27-44. PubMed ID: 21373966
[TBL] [Abstract][Full Text] [Related]
34. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.
Janes PW; Saha N; Barton WA; Kolev MV; Wimmer-Kleikamp SH; Nievergall E; Blobel CP; Himanen JP; Lackmann M; Nikolov DB
Cell; 2005 Oct; 123(2):291-304. PubMed ID: 16239146
[TBL] [Abstract][Full Text] [Related]
35. CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.
Gutwein P; Abdel-Bakky MS; Doberstein K; Schramme A; Beckmann J; Schaefer L; Amann K; Doller A; Kämpfer-Kolb N; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
J Cell Mol Med; 2009 Sep; 13(9B):3809-25. PubMed ID: 19426159
[TBL] [Abstract][Full Text] [Related]
36. The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10.
Lemieux GA; Blumenkron F; Yeung N; Zhou P; Williams J; Grammer AC; Petrovich R; Lipsky PE; Moss ML; Werb Z
J Biol Chem; 2007 May; 282(20):14836-44. PubMed ID: 17389606
[TBL] [Abstract][Full Text] [Related]
37. An arginine stretch limits ADAM10 exit from the endoplasmic reticulum.
Marcello E; Gardoni F; Di Luca M; Pérez-Otaño I
J Biol Chem; 2010 Apr; 285(14):10376-84. PubMed ID: 20100836
[TBL] [Abstract][Full Text] [Related]
38. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
39. A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
Zhang W; Liu S; Liu K; Wang Y; Ji B; Zhang X; Liu Y
J Int Med Res; 2014 Jun; 42(3):611-8. PubMed ID: 24670536
[TBL] [Abstract][Full Text] [Related]
40. ADAM10 as a target for anti-cancer therapy.
Moss ML; Stoeck A; Yan W; Dempsey PJ
Curr Pharm Biotechnol; 2008 Feb; 9(1):2-8. PubMed ID: 18289051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
